In a webcast published today in the cancer journal eCancer, Endomagnetics’ founder Quentin Pankhurst demonstrates the new SentiMag™ in action, and breast cancer surgeon Michael Douek describes his new clinical trial on the use of magnetic tracers for sentinel node detection.
You can watch Prof. Pankhurst’s and Dr Michael Douek’s interview with eCancer below (external link):
